Unlocking BLA, NDA, IND Submissions
Key considerations and LORENZ docuBridge training

Duration: 1 hour & 1 minute


If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch


Preparing and compiling eCTD sequences for BLA, NDA, and IND submissions has become commodity work. Nevertheless, requirements and specifications change regularly. Plus there is significant pressure on operational work to accelerate the publishing and submission process, while also lowering the costs.

The first part of this webinar will provide you with the theoretical background to plan, prepare and execute highly efficient and compliant eCTD sequences for the FDA. The focus will be on mandatory requirements and how you can leverage efficiency gains during the preparation phase and avoid hurdles right before the submission deadline. These insights are based on the experience of > 2500 eCTD sequences that PharmaLex is preparing with Lorenz docuBridge every year.

The second half of this webinar will feature a live demonstration of compiling submissions based on the BLA template using LORENZ docuBridge software. In particular, we will look at compiling Modules 1 and 3 as well as lifecycle operations while focusing on the main differences to other application types (IND and NDA).

Key Learnings

  •  eCTD submission for BLA
  •  Compilation and submission life cycle of a BLA
  •  Main differences to other application types such as IND and NDA

A full hour of inspirational speakers

Proud to bring inspirational speakers from across the globe.


Adair Turner

Principle, Consultant, Director RegOps, PharmaLex

Adair joined PharmaLex in April 2017 as Principal Consultant, Director Regulatory Operations, where she is responsible for electronic submission activities, regulatory information management and related topics in the US. She has a wealth of experience in managing hundreds of Regulatory submissions throughout the product lifecycle, leading cross-functional project teams, and implementing innovative technologies.

Parul Patel

Senior Product Consultant, LORENZ Life Sciences Group

Parul Patel joined LORENZ in 2016 as a Regulatory Solutions Engineer for LORENZ docuBridge. Since then, she has evolved into Senior Product Consultant for the NA market. She performs product trainings and prepares training materials for various customers globally. In addition to representing LORENZ at RAPS workshops since 2016, she led the training effort for a new regional regulatory agency client, including training content development; session schedules as well as working as the principal trainer and overall educational service delivery activities. Parul has worked in the RA field since 2002 and holds a B.S. in Industrial Engineering from New Jersey Institute of Technology, USA.

Karl-Heinz Loebel

Director, Principal Consultant RegOps Industry/Agency Liaisons, PharmaLex

Karl-Heinz Loebel has spent the last 15 years in Regulatory Affairs, focusing on electronic submission, data management and systems implementation. He has been responsible for PharmaLex eCTD submissions in traditional ICH regions ever since and is now also coordinating the extension of the company’s publishing capabilities to the requirements of the regions that joint the eCTD community most recently, like China and EAEU.

Akira Yamaguchi

CTO, LORENZ Life Sciences Group

Since 1995, Akira Yamaguchi's main field of activity has been electronic submission projects and the development of the entire docuBridge product line. Akira has frequently been a speaker around the world on the topic of electronic submissions and is one of the top internationally recognized experts in electronic submission design and processes. Between 1983 and 1994, he pursued an international career in management consulting and information technology at Hoechst AG and Software AG in Germany as well as Comshare International Ltd. in the UK.

Melissa Rapp

Manager, RegOps, PharmaLex

Melissa Rapp is a RegOps manager with 17 years of experience in submission publishing and management. At PharmaLex she has submitted 397 sequences through the FDA gateway. She has successfully managed the submission activities of two simultaneous ANDAs and has experience with applications in the US, Health Canada and EU. Her managerial role has involved conducting issue resolution and managing global resources to ensure client and agency-mandated timelines are met. 

Jan Wermusch

Product Manager, LORENZ Life Sciences Group

Jan Wermusch studied mathematics at the Humboldt University in Berlin and has more than 20 years of experience in the IT business. He joined LORENZ in 2004 as Quality Assurance Manager. In 2006 he assumed the position of Product Manager for LORENZ eValidator.